Schering AG hormone patch
Executive Summary
Schering AG estradiol/levonorgestrel transdermal combination patch deemed "not approvable" by FDA Oct. 8, Schering AG says. The NDA, originally filed June 29, 2000, received a previous "not approvable" letter in June 2001 (1"The Pink Sheet" July 9, 2001, p. 19)...